Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
AI 90-DAY FORECAST
NEUTRAL SIGNAL
██.█% Sign up free to reveal

Medline Inc. (MDLN) AI Forecast

Our AI analyzed Medline Inc.. Create a free account and follow it to see the 90-day price prediction.

Free account • 30-day free trial

$MDLN Neutral Signal Full forecast available

Medline Inc. (MDLN) AI Stock Price Forecast & Investment Analysis

Medline Inc. Stock Price Chart and Technical Analysis

Loading chart...

Medline Inc. (MDLN) - Comprehensive Stock Analysis & Investment Research

Deep dive into Medline Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on July 28, 2026, 8:28 a.m. (UTC)

Medline Inc. Investment Summary

When evaluating whether Medline Inc. (MDLN) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Medline Inc. (MDLN) operates within the Industrial Applications and Services sector, specifically in the Surgical & Medical Instruments & Apparatus industry. . With a market capitalization of $71 billion, the company is a large-cap stock offering relative stability combined with growth potential.

Financial Performance Analysis

Our comprehensive financial analysis covers Medline Inc.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Medline Inc. along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Medline Inc. is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Medline Inc.

Sign Up Free
Corporate Identity

Medline Inc. (Stock Symbol: MDLN) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Surgical & Medical Instruments & Apparatus industry. The company's shares are publicly traded on the Nasdaq exchange.

Leadership & Workforce

Detailed information about Medline Inc.'s leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Medline Inc....

Sector & Industry Analysis

In-depth sector dynamics and industry context for Medline Inc....

Unlock Full Company Profile

Get complete details about Medline Inc.

Sign Up Free
Revenue & Growth Analysis

Medline Inc. generates annual revenues of $29 billion , demonstrating substantial market presence and operational scale.

Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Medline Inc....

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Medline Inc....

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Medline Inc....

Unlock Financial Analysis

Get complete financial metrics for Medline Inc.

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Medline Inc.'s AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial

30-day free trial • Cancel anytime

Strategic Market Position

Medline Inc. strategically competes in the highly dynamic Surgical & Medical Instruments & Apparatus marketplace. As a large-cap market participant, the company has established significant competitive advantages and market presence. Large-cap companies typically benefit from brand recognition, operational scale, diverse revenue streams, and the financial resources to invest in research and development, marketing, and strategic acquisitions. This size category attracts substantial institutional ownership and analyst coverage.

Industry Competitive Landscape

Medline Inc. competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency

The company demonstrates exceptional operational efficiency through free cash flow generation of $1 billion annually . This substantial cash generation capability provides significant strategic flexibility for acquisitions, share repurchases, dividend growth, or debt reduction—all while maintaining operational investments necessary to defend market position.

Margin & Pricing Power Analysis

The company maintains a 26.4% gross margin reflecting moderate pricing power typical of many manufacturing, retail, or service businesses. While not exceptionally high, these margins provide adequate room for operating expenses and profit generation. Competitive pressures or cost increases could impact profitability if margins compress.

Operating margin of 7.8% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. Operating margin compression relative to gross margin suggests high operating expenses that may warrant efficiency improvements or reflect necessary growth investments.

Asset Utilization Efficiency

Asset turnover ratio of 0.74x indicates moderate asset turnover common in capital-intensive industries such as utilities, real estate, or heavy manufacturing. Lower turnover in these sectors is expected due to the significant infrastructure required for operations.

Financial Strength & Leverage

Medline Inc. (MDLN) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Medline Inc. stock analysis.

Deep dive into Medline Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Medline Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Medline Inc.: With a P/E ratio of 84.46, the market highly values future growth prospects.

P/E Ratio 84.46x
P/B Ratio 6.28x
Market Cap $70.74B
EPS $-0.01
Book Value/Share $6.33
Revenue/Share $16.23
FCF/Share $0.72
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Medline Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Medline Inc.: An ROE of 10.3% shows good shareholder value creation.

ROE 10.3%
ROA 3.0%
Gross Margin 26.4%
Operating Margin 7.8%
Net Margin 4.1%
EBT Margin 4.4%
Tax Rate 7.3%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Medline Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Medline Inc.:

D/E Ratio 1.74x
Financial Leverage 3.46x
Interest Coverage 6.9x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Medline Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Medline Inc.: Free cash flow of $1281M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $1.74B
Free Cash Flow $1.28B
Capital Spending -$464M
FCF/Sales 4.4%
CapEx/Sales 1.6%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Medline Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Medline Inc.: An asset turnover of 0.74x suggests room for improvement in asset utilization.

Asset Turnover 0.74x
Understanding Financial Statement Data

What these metrics mean: Key figures from Medline Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Medline Inc.: With annual revenue of $28920M, Medline Inc. operates at significant scale.

Income Statement
Total Revenue $28.92B
Operating Income $2.21B
Net Income $1.16B
R&D Expense $80M
SG&A Expense $4.52B
Cost of Goods Sold $20.91B
Balance Sheet Highlights (% Of Assets)
Total Liabilities 19665%
Dividend & Shareholder Information
Shares Outstanding 1782M
Growth Metrics (YoY)
Net Income Growth 4.1%
EPS Growth 0.0%

Latest Medline Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Medline Inc. (MDLN) stock price and investment outlook.

📰 Loading...

Medline Inc. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of Medline Inc. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ADGM ██% $11M x 1.9x
AEMD ██% $1M x 0.3x
ALUR ██% $6M x x
AMIX ██% $2M x 0.3x
ANGO ██% $570M x 3.3x
ANIK ██% $201M x 1.5x
AORT ██% $1.25B 107.3x 2.8x
APYX ██% $163M x 12.7x
ARAY ██% $27M x 0.6x
ATEC ██% $1.33B x x
ATRC ██% $1.90B 182.0x 3.7x
AURX ██% $49M x x
BAX ██% $12.02B x 2.0x
BBNX ██% $713M x 2.6x
BDX ██% $43.79B 38.5x 1.8x
BEAT ██% $29M x 45.9x
BJDX ██% $1M x 0.3x
BSX ██% $67.58B 19.0x 2.6x
BTCY ██% $2M x x
BVS ██% $838M 29.4x 4.4x
BWAY ██% $632M x x
CARL ██% $311M x 3.4x
CERS ██% $596M x 8.8x
CLPT ██% $438M x 23.2x
CODX ██% $7M x 0.5x
CTSO ██% $23M x 10.3x
CVRX ██% $129M x 4.4x
DCTH ██% $412M 733.5x 3.7x
DRIO ██% $55M x 0.9x
DRTS ██% $1.07B x 13.9x
DXCM ██% $28.31B 30.4x 9.6x
EBRCZ ██% $137M x 14.4x
EMBC ██% $204M 1.8x x
FEMY ██% $9M x 1.3x
FOFA ██% $27M 173.9x 28.2x
GCTK ██% $2M x x
GIPL ██% $170K x 0.3x
GKOS ██% $8.87B x 13.2x
GMED ██% $10.59B 18.1x 2.2x
GUTS ██% $127M x 6.0x
HAE ██% $3.62B 37.2x 4.5x
HRGN ██% $18M x 200.7x
HTFL ██% $2.18B x 7.7x
IART ██% $1.50B x 1.4x
ICCM ██% $10M x 1.1x
ICUI ██% $4.04B 87.1x 1.9x
IDXG ██% $43M 1.8x 1.9x
INBS ██% $4M x 0.5x
INSP ██% $1.47B 11.2x 1.9x
IRMD ██% $1.22B 51.5x 12.3x
IRTC ██% $3.68B x 22.9x
IVF ██% $2M x 0.1x
KIDS ██% $469M x 1.4x
KMTS ██% $1.33B x 5.1x
KRMD ██% $188M x 11.1x
LMAT ██% $2.26B 36.2x 5.6x
LNSR ██% $65M 2.2x 6.0x
LUCD ██% $172M x 43.1x
LUNG ██% $52M x 1.1x
LYRA ██% $920K x x
MBOT ██% $118M x 1.6x
MCAG ██% $37M x x
MDAI ██% $52M x x
MDLN ██% $70.74B 84.5x 6.3x
MDNC ██% $59M 65.1x 10.0x
MDXG ██% $634M 20.7x 2.6x
MMED ██% $4.59B x 1.3x
MMM ██% $87.46B 29.2x 29.6x
MMSI ██% $4.54B 32.6x 2.8x
MODD ██% $12M x 1.0x
NEPH ██% $41M 52.7x 3.8x
NMTC ██% $16M x 3.1x
NPCE ██% $498M x 34.4x
NSPR ██% $32M x 0.7x
NUMD ██% $2M x x
NVCR ██% $2.32B x 6.9x
NVNO ██% $7M x 0.3x
NXGL ██% $4M x 1.0x
NYXH ██% $147M x x
OBIO ██% $213M x 5.2x
ODYY ██% $710K x x
OFIX ██% $443M x 1.0x
OSRH ██% $15M x 0.1x
OSUR ██% $280M x 0.9x
PAVM ██% $32M x 0.8x
PDEX ██% $175M 14.6x 3.9x
PEN ██% $12.49B 73.0x 8.5x
PETV ██% $25M x 11.4x
PFSA ██% $930K x x
PLRZ ██% $29M x 1.1x
PLSE ██% $2.11B x 31.9x
PMI ██% $9M x 2.4x
PODD ██% $11.08B 36.6x 8.5x
PRCT ██% $999M x 2.9x
PREM ██% $2M x 0.6x
PROF ██% $249M x 4.2x
PSTV ██% $26M x 2.2x
PYPD ██% $77M x 7.0x
QTEX ██% $49M x 21.3x
RCEL ██% $142M x x
RDGL ██% $29M x 10.7x
RMD ██% $27.83B 18.3x 4.3x
RTGN ██% $75M x x
RVP ██% $20M x 0.3x
SGHT ██% $254M x 4.7x
SGP ██% $698M x 2.8x
SIBN ██% $728M x 4.1x
SIGY ██% $160K x x
SINT ██% $9M x 10.2x
SKIN ██% $95M x 1.7x
SNOA ██% $6M x 1.8x
SNWV ██% $51M 3.2x 27.7x
SOLV ██% $13.85B 9.7x 2.8x
SRTS ██% $50M x 1.1x
SSII ██% $681M x 12.5x
SSKN ██% $0.00M x 0.0x
STIM ██% $121M x 9.1x
STME ██% $6M x x
STVN ██% $5.45B x x
SYK ██% $129.82B 38.9x 5.7x
TCMD ██% $635M 31.3x 2.9x
TELA ██% $27M x x
TFX ██% $5.91B x 1.9x
TLSI ██% $267M x 20.8x
TMCI ██% $258M x 3.4x
TNDM ██% $1.15B x 8.7x
TNON ██% $3M x 1.7x
UFPT ██% $1.89B 27.5x 4.3x
USAQ ██% $5M 10.4x 3.0x
UTMD ██% $217M 20.0x 1.8x
VTAK ██% $1M x 0.1x
VVOS ██% $6M x x
VYCO ██% $2M x x
WST ██% $23.20B 41.1x 7.8x
XAIR ██% $4M x 0.6x
XTNT ██% $60M 33.0x 1.2x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Medline Inc. Stock Forecast

How accurate are Medline Inc. stock predictions?

Our AI model shows a 42% Spearman correlation coefficient for MDLN predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Medline Inc. stock price forecasts?

Our analysis considers Medline Inc.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Medline Inc. a good investment in 2025?

Based on our AI analysis, Medline Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Medline Inc. forecasts updated?

Medline Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want a simpler view of Medline Inc.?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...